| 國立臺灣大學 |
2012 |
Tumor lysis syndrome after transarterial chemoembolization plus portal venous embolization for hepatocellular carcinoma
|
Tsai, Wan-Ling; Liang, Po-Chin; Chen, Chien-Hung; 陳健弘; 梁博欽 |
| 臺大學術典藏 |
2018-09-10T09:15:18Z |
Tumor lysis syndrome after transarterial chemoembolization plus portal venous embolization for hepatocellular carcinoma
|
Tsai, Wan-Ling;Liang, Po-Chin;Chen, Chien-Hung; Tsai, W.-L. and Liang, P.-C. and Chen, C.-H.; 陳健弘 ;梁博欽; Tsai, Wan-Ling; PO-CHIN LIANG; Liang, Po-Chin; Chen, Chien-Hung |
| 臺大學術典藏 |
2020-08-11T08:36:52Z |
Tumor lysis syndrome after transarterial chemoembolization plus portal venous embolization for hepatocellular carcinoma
|
Tsai W.-L.; PO-CHIN LIANG; Chen C.-H. |
| 臺大學術典藏 |
2022-02-22T05:34:20Z |
Tumor lysis syndrome after transarterial chemoembolization plus portal venous embolization for hepatocellular carcinoma
|
Tsai W.-L.; Liang P.-C.; CHIEN-HUNG CHEN |
| 臺大學術典藏 |
2022-02-23T02:12:28Z |
Tumor lysis syndrome after transarterial chemoembolization plus portal venous embolization for hepatocellular carcinoma
|
Tsai W.-L.; Liang P.-C.; CHIEN-HUNG CHEN |
| 臺大學術典藏 |
2022-06-27T07:00:18Z |
Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer
|
Mok T.; Ladrera G.; Srimuninnimit V.; Sriuranpong V.; CHONG-JEN YU; Thongprasert S.; Sandoval-Tan J.; Lee J.S.; Fuerte F.; Shames D.S.; Klughammer B.; Truman M.; Perez-Moreno P.; Wu Y.-L. |
| 國立交通大學 |
2014-12-08T15:30:29Z |
Tumor Marker Detection by Aptamer-Functionalized Graphene Oxide
|
Lin, Ming-Yu; Lu, Yen-Pei; Grumezescu, Alexandru Mihai; Ho, Fu Han; Kao, Ying-Hsien; Yang, Yuh-Shyong; Yang, Chih-Hui |
| 國立臺灣科技大學 |
2013 |
Tumor marker detection by aptamer-functionalized graphene oxide
|
Lin, M.-Y.;Lu, Y.-P.;Grumezescu, A.M.;Ho, F.H.;Kao, Y.-H.;Yang, Y.-S.;Yang, C.-H. |
| 義守大學 |
2013-01 |
Tumor Marker Detection by Aptamer-Functionalized Graphene Oxide
|
Ming-Yu Lin;Yen-Pei Lu;Alexandru Mihai Grumezescu;Fu Han Ho;Ying-Hsien Kao;Yuh-Shyong Yang;Chih-Hui Yang |
| 高雄醫學大學 |
1997 |
Tumor markers in head and neck cancer
|
郭文烈 |
| 臺大學術典藏 |
2020-12-02T02:36:47Z |
Tumor markers of lung cancer: carcinoembryonic antigen and TuMark.
|
PAN-CHYR YANG; Luh K.T.; Lee Y.C.; Kuo S.H.; Huang T.W. |
| 臺大學術典藏 |
2021-05-26T03:36:17Z |
Tumor markers of lung cancer: carcinoembryonic antigen and TuMark.
|
Yang P.C.; KWEN-TAY LUH; Lee Y.C.; Kuo S.H.; Huang T.W. |
| 國立臺灣大學 |
1989-09 |
Tumor Markers of Lung Cancer:Carcinoembryonic Antigen and Tumark
|
楊泮池; 郭壽雄; Luh, Kwen-Ttay; Yang, Pan-Chyr; Kuo, Sow-Hsong; Luh, Kwen-Ttay |
| 臺大學術典藏 |
2021-11-18T05:54:44Z |
Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts
|
Lee P.-J.; Ho C.-C.; Ho H.; Chen W.-J.; Lin C.-H.; Lai Y.-H.; Juan Y.-C.; Chu W.-C.; Lee J.-H.; SHENG-FANG SU; Chen H.-Y.; Chen J.J.W.; Chang G.-C.; Li K.-C.; Yang P.-C.; Chen H.-W. |
| 臺大學術典藏 |
2021-11-17T06:27:11Z |
Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts
|
Lee, Pei-Jung; CHAO-CHI HO; Ho, Hao; Chen, Wan-Jiun; Lin, Chiu-Hua; Lai, Yi-Hua; Juan, Yi-Chen; Chu, Wen-Chung; Lee, Jia-Hua; Su, Sheng-Fang; Chen, Hsuan-Yu; Chen, Jeremy J W; Chang, Gee-Chen; Li, Ker-Chau; Yang, Pan-Chyr; Chen, Huei-Wen |
| 臺大學術典藏 |
2022-03-04T08:19:17Z |
Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts
|
Lee, Pei Jung; Ho, Chao Chi; Ho, Hao; Chen, Wan Jiun; Lin, Chiu Hua; Lai, Yi Hua; Juan, Yi Chen; Chu, Wen Chung; Lee, Jia Hua; Su, Sheng Fang; Chen, Hsuan Yu; Chen, Jeremy J.W.; Chang, Gee Chen; Li, Ker Chau; Yang, Pan Chyr; HUEI-WEN CHEN |
| 臺大學術典藏 |
2022-03-09T03:12:17Z |
Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts
|
Lee P.-J.; Ho C.-C.; Ho H.; Chen W.-J.; Lin C.-H.; Lai Y.-H.; Juan Y.-C.; Chu W.-C.; Lee J.-H.; Su S.-F.; Chen H.-Y.; Chen J.J.W.; Chang G.-C.; Li K.-C.; Yang P.-C.; HUEI-WEN CHEN |
| 臺大學術典藏 |
2022-04-28T06:03:15Z |
Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts
|
Lee, Pei Jung; CHAO-CHI HO; Ho, Hao; Chen, Wan Jiun; Lin, Chiu Hua; Lai, Yi Hua; Juan, Yi Chen; Chu, Wen Chung; Lee, Jia Hua; SHENG-FANG SU; Chen, Hsuan Yu; Chen, Jeremy J.W.; Chang, Gee Chen; Li, Ker Chau; PAN-CHYR YANG; HUEI-WEN CHEN |
| 中山醫學大學 |
2021 |
Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts
|
Lee, PJ; Ho, CC; Ho, H; Chen, WJ; Lin, CH; Lai, YH; Juan, YC; Chu, WC; Lee, JH; Su, SF; Chen, HY; Chen, JJW; Chang, GC; Li, KC; Yang, PC; Chen, HW |
| 臺大學術典藏 |
2022-09-08T08:27:31Z |
Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts
|
Lee, Pei-Jung; Ho, Chao-Chi; Ho, Hao; Chen, Wan-Jiun; Lin, Chiu-Hua; Lai, Yi-Hua; Juan, Yi-Chen; Chu, Wen-Chung; Lee, Jia-Hua; Su, Sheng-Fang; Chen, Hsuan-Yu; Chen, Jeremy J W; Chang, Gee-Chen; Li, Ker-Chau; PAN-CHYR YANG; Chen, Huei-Wen |
| 國立臺灣科技大學 |
2016 |
Tumor Microenvironment-Responsive Nanoparticle Delivery of Chemotherapy for Enhanced Selective Cellular Uptake and Transportation within Tumor
|
Huang, W.-C;Chen, S.-H;Chiang, W.-H;Huang, C.-W;Lo, C.-L;Chern, Chern C.-S;Chiu, H.-C. |
| 國立臺灣科技大學 |
2020 |
Tumor motion tracking based on a four-dimensional computed tomography respiratory motion model driven by an ultrasound tracking technique
|
Ting, L.-L.;Chuang, H.-C.;Liao, A.-H.;Kuo, C.-C.;Yu, H.-W.;Tsai, H.-C.;Tien, D.-C.;Jeng, S.-C.;Chiou, J.-F. |
| 中山醫學大學 |
2020 |
Tumor Multifocality is a Significant Risk Factor of Urinary Bladder Recurrence after Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma: A Single-Institutional Study
|
Chen, CS; Li, JR; Wang, SS; Yang, CK; Cheng, CL; Yang, CR; Ou, YC; Ho, HC; Lin, CY; Hung, SC; Chen, CC; Wang, SC; Chiu, KY; Yang, SF |
| 臺大學術典藏 |
2020-06-17T03:01:27Z |
Tumor mutation burden and recurrent tumors in hereditary lung cancer
|
Hsu Y.-C.; Chang Y.-H.; Chang G.-C.; Ho B.-C.; Yuan S.-S.; Li Y.-C.; Zeng J.-W.; SUNG-LIANG YU; Li K.-C.; Yang P.-C.; Chen H.-Y.; Hsu Y.-C.;Chang Y.-H.;Chang G.-C.;Ho B.-C.;Yuan S.-S.;Li Y.-C.;Zeng J.-W.;Sung-Liang Yu;Li K.-C.;Yang P.-C.;Chen H.-Y. |
| 臺大學術典藏 |
2020-12-02T02:33:09Z |
Tumor mutation burden and recurrent tumors in hereditary lung cancer
|
Hsu Y.-C.; Chang Y.-H.; Chang G.-C.; Ho B.-C.; Yuan S.-S.; Li Y.-C.; Zeng J.-W.; Yu S.-L.; Li K.-C.; Pan-Chyr Yang; Chen H.-Y.; Hsu Y.-C.; PAN-CHYR YANG et al. |
